The cardiologist's role in increasing the rate of mitral valve repair in degenerative disease

Purpose of review To highlight the relevance of preoperative differentiation of degenerative mitral valve disease based on etiology (predominantly Barlow's Disease or fibroelastic deficiency) and severity of lesions with an emphasis on how such differentiation by the cardiologist can result in increased rate of mitral valve repair. Recent findings In the hands of reference mitral valve-repair surgeons, 95–100% of degenerative valves are repairable, regardless of etiology; however, in the general cardiac surgical community, the repair rates are around 50%. In contrast to fibroelastic deficiency, Barlow's valves have more complex pathology and require advanced techniques to effect a repair. We present a simple algorithm that enables the cardiologist to stratify degenerative mitral valves into those that are repairable by any experienced cardiac surgeon and those that require reference-center referral to deliver a high probability of repair. Such targeted referral strategy should result in near 100% repair rate for degenerative disease. Summary Essentially, all degenerative mitral valves are repairable. By matching echocardiographic findings to the appropriate surgical skill level required to consistently deliver a repair, valve replacement for degenerative mitral valve disease should be infrequent.

[1]  P. Marchand,et al.  The significance of late systolic murmurs , 1963 .

[2]  J. O. Humphries,et al.  Prolapse of the mitral valve: clinical and cine-angiocardiographic findings. , 1966, British heart journal.

[3]  A Piwnica,et al.  Reconstructive surgery of mitral valve incompetence: ten-year appraisal. , 1980, The Journal of thoracic and cardiovascular surgery.

[4]  L. Shapiro,et al.  Superiority of mitral valve repair in surgery for degenerative mitral regurgitation. , 1997, European heart journal.

[5]  M. Enriquez-Sarano,et al.  Natural history of mitral regurgitation due to flail leaflets. , 1997, European heart journal.

[6]  N G Smedira,et al.  Durability of mitral valve repair for degenerative disease. , 1998, The Journal of thoracic and cardiovascular surgery.

[7]  M. Enriquez-Sarano,et al.  Timing of mitral valve surgery , 2002, Heart.

[8]  M. Enriquez-Sarano,et al.  Natural History of Asymptomatic Mitral Valve Prolapse in the Community , 2002, Circulation.

[9]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  B. Lytle,et al.  Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. , 2003, The Journal of thoracic and cardiovascular surgery.

[11]  M. Enriquez-Sarano,et al.  Quantitative determinants of the outcome of asymptomatic mitral regurgitation. , 2005, The New England journal of medicine.

[12]  M. Enriquez-Sarano,et al.  Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. , 2006, The Annals of thoracic surgery.

[13]  David H Adams,et al.  Large annuloplasty rings facilitate mitral valve repair in Barlow's disease. , 2006, The Annals of thoracic surgery.

[14]  G. Laufer,et al.  Comparison of three-dimensional imaging to transesophageal echocardiography for preoperative evaluation in mitral valve prolapse. , 2006, The American journal of cardiology.

[15]  M. Schemper,et al.  Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation , 2006, Circulation.

[16]  B. Keogh,et al.  Mitral repair best practice: proposed standards , 2005, Heart.

[17]  David H. Adams,et al.  Current concepts in mitral valve repair for degenerative disease , 2006, Heart Failure Reviews.

[18]  N. Nanda,et al.  Usefulness of Live/Real Time Three‐Dimensional Transthoracic Echocardiography in the Identification of Individual Segment/Scallop Prolapse of the Mitral Valve , 2006, Echocardiography.

[19]  B. Healy The mitral valve question. , 2007, U.S. news & world report.

[20]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[21]  David H Adams,et al.  Etiologic classification of degenerative mitral valve disease: Barlow's disease and fibroelastic deficiency. , 2007, Seminars in thoracic and cardiovascular surgery.

[22]  T. David Outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. , 2007, Seminars in thoracic and cardiovascular surgery.

[23]  I. Simpson,et al.  The evaluation of real-time 3-dimensional transthoracic echocardiography for the preoperative functional assessment of patients with mitral valve prolapse: a comparison with 2-dimensional transesophageal echocardiography. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  M. J. Wade,et al.  Usefulness of Live/Real Time Three‐Dimensional Transthoracic Echocardiography in the Assessment of Descending Thoracic Aorta Graft Dehiscence , 2010, Echocardiography.